Covered recipient · General Payments record
ALICE B NEWELL
General Payments · PY2018–2024
$1,201.75
- Reported across 55 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $335.73 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $107.92 | 6 |
| Amgen Inc. | $61.22 | 4 |
| Lilly USA, LLC | $58.47 | 2 |
| Organon LLC | $47.55 | 2 |
| PFIZER INC. | $44.45 | 2 |
| Merck Sharp & Dohme Corporation | $16.12 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $16.22 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111661563 | CMS |
| Amgen Inc. | $15.13 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111661565 | CMS |
| Amgen Inc. | $13.87 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111661567 | CMS |
| Amgen Inc. | $16.00 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111661569 | CMS |
| Astellas Pharma US Inc | $16.46 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139294136 | CMS |
| Astellas Pharma US Inc | $19.95 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139274006 | CMS |
| Astellas Pharma US Inc | $19.47 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139305546 | CMS |
| Astellas Pharma US Inc | $19.28 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139356791 | CMS |
| Astellas Pharma US Inc | $15.67 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139267780 | CMS |
| Astellas Pharma US Inc | $17.09 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139406829 | CMS |
| Lilly USA, LLC | $29.74 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136015927 | CMS |
| Lilly USA, LLC | $28.73 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136023450 | CMS |
| Merck Sharp & Dohme LLC | $16.12 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141871879 | CMS |
| Organon Llc | $27.79 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136212625 | CMS |
| Organon Llc | $19.76 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136212623 | CMS |
| PFIZER INC. | $23.60 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131770592 | CMS |
| PFIZER INC. | $20.85 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131642539 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.